NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
Despite growth in value-based programs, there are still many foundational barriers preventing further adoption. Join industry experts from NantHealth and...
The COVID-19 pandemic has spurred a movement of online health disinformation, leaving consumers and patients to wonder what online information...
The complexity of cancer care continues to increase, and payers are under pressure to balance the dramatic rise in costs...
Professional burnout in the healthcare industry is increasingly challenging, and the COVID-19 pandemic added stressors to clinicians’ already busy workloads....
While many payer and provider organizations have found early success with value-based efforts, barriers around data interoperability still prevent the...
Authorizations are among the most manual and costly transactions for health plans and providers alike. Health plans spend a significant...
While the practice of healthcare continues to make advances in patient care with new research, procedures, and drug therapies, the...
Biosimilars are becoming quite the buzzword in cancer treatment, but cost, regulation, safety and efficacy are driving questions amongst payers...
Learn how payers can curb out-of-control cancer costs and address the inevitable swing to consumer-driven approaches to care. This webcast...